HUP9904091A3 - N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics - Google Patents

N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics

Info

Publication number
HUP9904091A3
HUP9904091A3 HU9904091A HUP9904091A HUP9904091A3 HU P9904091 A3 HUP9904091 A3 HU P9904091A3 HU 9904091 A HU9904091 A HU 9904091A HU P9904091 A HUP9904091 A HU P9904091A HU P9904091 A3 HUP9904091 A3 HU P9904091A3
Authority
HU
Hungary
Prior art keywords
benzothiazol
therapeutics
piperidine
preparation
application
Prior art date
Application number
HU9904091A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of HUP9904091A2 publication Critical patent/HUP9904091A2/hu
Publication of HUP9904091A3 publication Critical patent/HUP9904091A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
HU9904091A 1996-10-01 1997-09-26 N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics HUP9904091A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9611925A FR2753970B1 (fr) 1996-10-01 1996-10-01 Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
HUP9904091A2 HUP9904091A2 (hu) 2000-05-28
HUP9904091A3 true HUP9904091A3 (en) 2000-07-28

Family

ID=9496217

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904091A HUP9904091A3 (en) 1996-10-01 1997-09-26 N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics

Country Status (23)

Country Link
EP (1) EP0929550A1 (es)
JP (1) JP2001501217A (es)
KR (1) KR20000048767A (es)
CN (1) CN1230959A (es)
AR (1) AR009105A1 (es)
AU (1) AU722147B2 (es)
BG (1) BG103271A (es)
BR (1) BR9711842A (es)
CA (1) CA2266510A1 (es)
CO (1) CO4650030A1 (es)
CZ (1) CZ112699A3 (es)
EE (1) EE9900135A (es)
FR (1) FR2753970B1 (es)
HU (1) HUP9904091A3 (es)
IL (1) IL128902A (es)
NO (1) NO991581L (es)
NZ (1) NZ334553A (es)
PL (1) PL332648A1 (es)
SK (1) SK42299A3 (es)
TR (1) TR199900634T2 (es)
TW (1) TW438800B (es)
WO (1) WO1998014444A1 (es)
ZA (1) ZA978772B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9725541D0 (en) * 1997-12-02 1998-02-04 Pharmacia & Upjohn Spa Amino-benzothiazole derivatives
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
IL153278A0 (en) * 2000-06-21 2003-07-06 Hoffmann La Roche Benzothiazole derivatives
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
MXPA06004304A (es) * 2003-10-24 2006-06-05 Hoffmann La Roche Antagonistas del receptor ccr-3.
NZ550763A (en) 2004-05-24 2010-07-30 Hoffmann La Roche 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
WO2006048172A1 (en) 2004-11-05 2006-05-11 F. Hoffmann-La Roche Ag Process for preparation of isonicotinic acid derivatives
ATE460417T1 (de) 2005-03-23 2010-03-15 Hoffmann La Roche Acetylenylpyrazolopyrimidinderivate als mglur2- antagonsten
AU2006298829B2 (en) 2005-09-27 2011-03-03 F. Hoffmann-La Roche Ag Oxadiazolyl pyrazolo-pyrimidines as mGluR2 antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법

Also Published As

Publication number Publication date
AU4463897A (en) 1998-04-24
PL332648A1 (en) 1999-09-27
IL128902A (en) 2001-07-24
HUP9904091A2 (hu) 2000-05-28
KR20000048767A (ko) 2000-07-25
BR9711842A (pt) 1999-08-24
FR2753970A1 (fr) 1998-04-03
EP0929550A1 (fr) 1999-07-21
FR2753970B1 (fr) 1998-10-30
WO1998014444A1 (fr) 1998-04-09
ZA978772B (en) 1998-03-27
CZ112699A3 (cs) 1999-06-16
CO4650030A1 (es) 1998-09-03
NZ334553A (en) 2000-11-24
TW438800B (en) 2001-06-07
NO991581L (no) 1999-06-01
IL128902A0 (en) 2000-02-17
SK42299A3 (en) 1999-12-10
JP2001501217A (ja) 2001-01-30
CN1230959A (zh) 1999-10-06
BG103271A (en) 2000-05-31
AR009105A1 (es) 2000-03-08
EE9900135A (et) 1999-12-15
NO991581D0 (no) 1999-03-30
TR199900634T2 (xx) 1999-06-21
CA2266510A1 (en) 1998-04-09
AU722147B2 (en) 2000-07-20

Similar Documents

Publication Publication Date Title
ZA976222B (en) N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use.
IL111148A0 (en) Imidazol-4- ylpiperidine derivatives, their preparation and their application in therapeutics
HUP9801817A3 (en) Dolastatin derivatives, their preparation and use
SG79212A1 (en) Reactive dyes, their preparation and use
CY2291B1 (en) 1H-pyridoa3,4-buindole-4-carboxamide derivatives preparation and application thereof in therapeutics
HUP9904032A3 (en) 1,2,4-benzothiadiazine derivatives,their preparation and use
AU9633098A (en) Benzoxazine derivatives, preparation and application in therapy
ZA978089B (en) 3,4-diaryloxazolone derivatives, their methods of preparation, and their use in therapeutics.
ZA988921B (en) 3,4-diarylthiazolin-2-one or -2-thione derivatives their methods of preparation and their uses in therapeutics
AU5591296A (en) N-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl)benzamide derivatives, their preparation and their application in therapeutics
HUP9904091A3 (en) N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics
ZA9725B (en) 4,5-Dihydronaphth[1,2-c]isoxazoles and derivatives thereof
ZA972894B (en) Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics.
ZA977767B (en) Benzylamine derivatives, their preparation and their application in therapeutics.
IL123535A0 (en) Benzoxazindione derivatives and their use
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
ZA9710515B (en) N-(imidazolybutyl) benezenesulphonamide derivatives, their preparation and their application in therapeutics.
AU1724697A (en) Novel aminophenol derivatives and their use
SG81913A1 (en) Reactive dyes, their preparation and use
GB2324090B (en) 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use
AU3448097A (en) 1-oxo-1,2-dihydroisoquinoline-4-propanamide derivatives and their application in therapeutics
ZA982358B (en) Benzenesulphonamide derivatives their preparation and their application in therapeutics
ZA9811651B (en) 1,2,4-Benzothiadiazine derivatives their preparation and use
ZA967558B (en) Alpha-phenylpiperidine-1-propanol derivatives their preparation and their application in therapeutics
DK0906297T3 (da) 1,2,4-Benzothiadiazinderivater, fremstilling og anvendelse deraf